SCHEMBL27865682

SCHEMBL27865682

NCc1ccccc1CC(=O)Nc1ccc(-c2ccc3ncc(N4CCN(c5ccncc5)CC4)nc3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 4/20 0.41
▸ DRD2 P14416 4/20 0.41
▸ MAPT P10636 6/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ GAA P10253 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ WNT3A P56704 2/20 0.39
▸ JAK3 P52333 2/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ HCAR2 Q8TDS4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10179687 0.90 KDM4E (0.43) HTR1ADRD2MAPTKDM4EALDH1A1
SCHEMBL1443193 0.90 MAPT (0.46) HTR1ADRD2MAPTKDM4EALDH1A1
SCHEMBL1442780 0.90 F2 (0.44) HTR1ADRD2MAPTKDM4EALDH1A1
SCHEMBL27882033 0.88 HTR1A (0.47) HTR1ADRD2MAPTMEN1KMT2A
SCHEMBL1442495 0.88 HTR1A (0.52) HTR1ADRD2MAPTKDM4EALDH1A1
SCHEMBL10178956 0.88 MAPT (0.55) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL10179432 0.88 HCRTR1 (0.41) HTR1ADRD2MAPTKDM4EALDH1A1
SCHEMBL27882087 0.88 WNT3A (0.44) HTR1ADRD2MAPTKDM4EALDH1A1
SCHEMBL1443398 0.87 HTR1A (0.54) HTR1ADRD2MAPTKDM4EALDH1A1
SCHEMBL1442833 0.86 HTR1A (0.52) HTR1ADRD2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596932-A Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors BAYER SCHERING PHARMA AG 2012-07-18 — — CN claimed
Send feedback